SATT AxLR
Overview
SATT AxLR is a technology transfer accelerator based in France that funds and develops innovations from academic research in sectors including health, biotechnology, agronomy, chemistry, and IT.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nervosave Therapeutics | Nov 2025 | Seed | Lead |
| Terratis | Dec 2024 | Early Funding | Co-investor |
| SPIMA Therapeutics | Sep 2024 | Seed | Lead |
| Bliss Ecospray | Jan 2021 | Pre Seed | Co-investor |
| BionomeeX | Aug 2020 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SATT AxLR based?
SATT AxLR is headquartered in Montpellier, France.
When was SATT AxLR founded?
SATT AxLR was founded in 2012.
How many portfolio companies does SATT AxLR have?
SATT AxLR has 10 portfolio companies in Caplight's dataset.
What are some companies in SATT AxLR's portfolio?
Recent investments visible on Caplight include Nervosave Therapeutics, Terratis, SPIMA Therapeutics, Bliss Ecospray, BionomeeX.
What was SATT AxLR's most recent investment?
SATT AxLR's most recent investment on Caplight was in Nervosave Therapeutics in 2025.
What sectors does SATT AxLR focus on?
SATT AxLR focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Telecommunications & Networking, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does SATT AxLR focus on?
SATT AxLR typically invests at the Early stage.